• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质辅助激光解吸电离-质谱成像:深入理解原发性胰腺导管腺癌及其转移的有力手段。

MALDI-MSI: A Powerful Approach to Understand Primary Pancreatic Ductal Adenocarcinoma and Metastases.

机构信息

Institute of Pathology, School of Medicine, Technical University of Munich, Trogerstraße 18, 81675 Munich, Germany.

German Cancer Consortium (DKTK), Partner Site Munich, 81675 Munich, Germany.

出版信息

Molecules. 2022 Jul 27;27(15):4811. doi: 10.3390/molecules27154811.

DOI:10.3390/molecules27154811
PMID:35956764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9369872/
Abstract

Cancer-related deaths are very commonly attributed to complications from metastases to neighboring as well as distant organs. Dissociate response in the treatment of pancreatic adenocarcinoma is one of the main causes of low treatment success and low survival rates. This behavior could not be explained by transcriptomics or genomics; however, differences in the composition at the protein level could be observed. We have characterized the proteomic composition of primary pancreatic adenocarcinoma and distant metastasis directly in human tissue samples, utilizing mass spectrometry imaging. The mass spectrometry data was used to train and validate machine learning models that could distinguish both tissue entities with an accuracy above 90%. Model validation on samples from another collection yielded a correct classification of both entities. Tentative identification of the discriminative molecular features showed that collagen fragments (COL1A1, COL1A2, and COL3A1) play a fundamental role in tumor development. From the analysis of the receiver operating characteristic, we could further advance some potential targets, such as histone and histone variations, that could provide a better understanding of tumor development, and consequently, more effective treatments.

摘要

癌症相关的死亡通常归因于转移到邻近和远处器官的并发症。胰腺腺癌治疗中的分离反应是治疗成功率低和生存率低的主要原因之一。这种行为不能用转录组学或基因组学来解释;然而,在蛋白质水平上可以观察到组成上的差异。我们利用质谱成像技术,直接在人类组织样本中对原发性胰腺腺癌和远处转移的蛋白质组组成进行了特征描述。质谱数据用于训练和验证机器学习模型,这些模型可以区分这两种组织实体,准确率超过 90%。对来自另一个样本集的样本进行模型验证,得到了对这两种实体的正确分类。对有区别的分子特征的初步鉴定表明,胶原片段(COL1A1、COL1A2 和 COL3A1)在肿瘤发展中起着重要作用。从接收者操作特征的分析中,我们可以进一步提出一些潜在的靶点,如组蛋白和组蛋白变体,这可以更好地了解肿瘤的发展,并因此提供更有效的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/9369872/c9fea8d8c0d4/molecules-27-04811-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/9369872/e1851d40b6c1/molecules-27-04811-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/9369872/f311c6362438/molecules-27-04811-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/9369872/c9fea8d8c0d4/molecules-27-04811-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/9369872/e1851d40b6c1/molecules-27-04811-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/9369872/f311c6362438/molecules-27-04811-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400c/9369872/c9fea8d8c0d4/molecules-27-04811-g003.jpg

相似文献

1
MALDI-MSI: A Powerful Approach to Understand Primary Pancreatic Ductal Adenocarcinoma and Metastases.基质辅助激光解吸电离-质谱成像:深入理解原发性胰腺导管腺癌及其转移的有力手段。
Molecules. 2022 Jul 27;27(15):4811. doi: 10.3390/molecules27154811.
2
Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging.通过基质辅助激光解吸电离质谱成像开发用于区分胰腺导管腺癌和胰腺神经内分泌肿瘤的类别预测模型
Proteomics Clin Appl. 2019 Jan;13(1):e1800046. doi: 10.1002/prca.201800046. Epub 2018 Dec 19.
3
MALDI Mass Spectrometry Imaging for the Distinction of Adenocarcinomas of the Pancreas and Biliary Tree.基质辅助激光解吸电离质谱成像在胰腺和胆道腺癌鉴别诊断中的应用。
Molecules. 2022 May 27;27(11):3464. doi: 10.3390/molecules27113464.
4
Proteomic Analysis of Metastasis-Specific Biomarkers in Pancreatic Cancer: Galectin-1 Plays an Important Metastatic Role in Pancreatic Cancer.胰腺癌转移特异性生物标志物的蛋白质组学分析:半乳糖凝集素-1在胰腺癌转移中起重要作用。
J Pharm Biomed Anal. 2020 Jul 15;186:113300. doi: 10.1016/j.jpba.2020.113300. Epub 2020 Apr 25.
5
MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer.基质辅助激光解吸电离成像质谱法用于胰腺癌癌前病变的原位蛋白质组分析。
PLoS One. 2012;7(6):e39424. doi: 10.1371/journal.pone.0039424. Epub 2012 Jun 26.
6
Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival.无标记蛋白质组学揭示了生存期短或长的胰腺导管腺癌患者之间血清蛋白水平存在差异。
Tumour Biol. 2020 Jun;42(6):1010428320936410. doi: 10.1177/1010428320936410.
7
Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.利用蛋白质芯片技术对胰腺腺癌组织进行蛋白质组学分类。
Gastroenterology. 2006 May;130(6):1670-8. doi: 10.1053/j.gastro.2006.02.036. Epub 2006 Mar 6.
8
Classification of Pancreatic Ductal Adenocarcinoma Using MALDI Mass Spectrometry Imaging Combined with Neural Networks.使用基质辅助激光解吸电离质谱成像结合神经网络对胰腺导管腺癌进行分类
Cancers (Basel). 2023 Jan 22;15(3):686. doi: 10.3390/cancers15030686.
9
Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases.福尔马林固定石蜡包埋胰腺导管腺癌及淋巴结转移的蛋白质组。
J Pathol. 2012 Apr;226(5):756-63. doi: 10.1002/path.3959. Epub 2012 Jan 17.
10
Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma.激光捕获显微切割联合二维电泳在胰腺导管腺癌差异表达蛋白发现中的应用
Proteomics. 2003 Oct;3(10):1988-2001. doi: 10.1002/pmic.200300466.

引用本文的文献

1
Evaluating Biocompatibility: From Classical Techniques to State-of-the-Art Functional Proteomics.评估生物相容性:从经典技术到最先进的功能蛋白质组学
Nanomaterials (Basel). 2025 Jul 3;15(13):1032. doi: 10.3390/nano15131032.
2
The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice.胰腺癌进展中的I型胶原蛋白悖论:微环境保护者变成肿瘤帮凶。
J Transl Med. 2025 Jul 4;23(1):744. doi: 10.1186/s12967-025-06778-8.
3
Exploring new frontiers in type 1 diabetes through advanced mass-spectrometry-based molecular measurements.

本文引用的文献

1
Prognostic Value of Stromal Type IV Collagen Expression in Small Invasive Breast Cancers.IV型胶原基质表达在小侵袭性乳腺癌中的预后价值
Front Mol Biosci. 2022 May 25;9:904526. doi: 10.3389/fmolb.2022.904526. eCollection 2022.
2
MALDI Mass Spectrometry Imaging for the Distinction of Adenocarcinomas of the Pancreas and Biliary Tree.基质辅助激光解吸电离质谱成像在胰腺和胆道腺癌鉴别诊断中的应用。
Molecules. 2022 May 27;27(11):3464. doi: 10.3390/molecules27113464.
3
family: potential prognostic biomarkers and therapeutic targets for gastric cancer.
通过基于先进质谱的分子测量探索1型糖尿病的新领域。
Trends Mol Med. 2024 Dec;30(12):1137-1151. doi: 10.1016/j.molmed.2024.07.009. Epub 2024 Aug 15.
4
Advances in Imaging Mass Spectrometry for Biomedical and Clinical Research.用于生物医学和临床研究的成像质谱技术进展
Trends Analyt Chem. 2023 Dec;169. doi: 10.1016/j.trac.2023.117344. Epub 2023 Oct 14.
5
Spatially resolved detection of small molecules from press-dried plant tissue using MALDI imaging.使用基质辅助激光解吸电离成像技术对压榨干燥植物组织中的小分子进行空间分辨检测。
Appl Plant Sci. 2023 Sep 11;11(5):e11539. doi: 10.1002/aps3.11539. eCollection 2023 Sep-Oct.
6
Proteomics-Driven Biomarkers in Pancreatic Cancer.蛋白质组学驱动的胰腺癌生物标志物
Proteomes. 2023 Aug 7;11(3):24. doi: 10.3390/proteomes11030024.
7
Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging.基于质谱成像技术的乳腺癌激素受体和 HER2 状态的特征分析。
Int J Mol Sci. 2023 Feb 2;24(3):2860. doi: 10.3390/ijms24032860.
8
Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice.肿瘤蛋白质组学技术的进展:迈向临床实践转化
Proteomes. 2023 Jan 10;11(1):2. doi: 10.3390/proteomes11010002.
家族:胃癌潜在的预后生物标志物和治疗靶点。
Transl Cancer Res. 2020 Sep;9(9):5218-5232. doi: 10.21037/tcr-20-517.
4
The Impact of Histological Annotations for Accurate Tissue Classification Using Mass Spectrometry Imaging.组织学注释对使用质谱成像进行准确组织分类的影响
Metabolites. 2021 Oct 30;11(11):752. doi: 10.3390/metabo11110752.
5
A Mass Spectrometry Imaging Based Approach for Prognosis Prediction in UICC Stage I/II Colon Cancer.一种基于质谱成像的UICC I/II期结肠癌预后预测方法。
Cancers (Basel). 2021 Oct 26;13(21):5371. doi: 10.3390/cancers13215371.
6
Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging.通过基质辅助激光解吸电离质谱成像技术获取的胰腺癌预后标志物的肽段特征图谱
Biology (Basel). 2021 Oct 12;10(10):1033. doi: 10.3390/biology10101033.
7
Cross-Normalization of MALDI Mass Spectrometry Imaging Data Improves Site-to-Site Reproducibility.MALDI 质谱成像数据的跨标准化可提高站点间的重现性。
Anal Chem. 2021 Aug 3;93(30):10584-10592. doi: 10.1021/acs.analchem.1c01792. Epub 2021 Jul 23.
8
Deep Learning in Pancreatic Tissue: Identification of Anatomical Structures, Pancreatic Intraepithelial Neoplasia, and Ductal Adenocarcinoma.深度学习在胰腺组织中的应用:解剖结构、胰腺上皮内瘤变和导管腺癌的识别。
Int J Mol Sci. 2021 May 20;22(10):5385. doi: 10.3390/ijms22105385.
9
Tubulin Beta 2C Chain (TBB2C), a Potential Marker of Ovarian Cancer, an Insight from Ovarian Cancer Proteome Profile.微管蛋白β2C链(TBB2C),一种潜在的卵巢癌标志物,来自卵巢癌蛋白质组图谱的见解
ACS Omega. 2021 Apr 13;6(16):10506-10514. doi: 10.1021/acsomega.0c03262. eCollection 2021 Apr 27.
10
Implementation of Mass Spectrometry Imaging in Pathology: Advances and Challenges.质谱成像技术在病理学中的应用:进展与挑战。
Clin Lab Med. 2021 Jun;41(2):173-184. doi: 10.1016/j.cll.2021.03.001. Epub 2021 Apr 24.